Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. From the ones listed this time, here's a few in our areas of research interest:
Pandya A, Sy S, Cho S, et. al. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. JAMA. 2015 Jul 14;314(2):142-50. doi: 10.1001/jama.2015.6822. PubMed PMID: 26172894.
Vallejo-Torres L, Castilla I, Couce ML, et. al. Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency. Pediatrics. 2015 Jul 13. [Epub ahead of print] PubMed PMID: 26169436.
Li R, Qu S, Zhang P, Chattopadhyay S, et. al. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015 Jul 14. [Epub ahead of print] PubMed PMID: 26167962.
Campbell JR, Sasitharan T, Marra F. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection. Appl Health Econ Health Policy. 2015 Jul 1. [Epub ahead of print] PubMed PMID: 26129810.
Quartuccio L, di Bidino R, Ruggeri M, et. al. Cost-Effectiveness Analysis of Two Rituximab Retreatment Regimens for Longstanding Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015 Jul;67(7):947-55. PubMed PMID: 25581074.